Breaking News

TOT Biopharm Opens Suzhou Production Facility

December 3, 2012

Completes first stage of construction

TOT Biopharm Co. Ltd. has completed the first stage of construction of its $100 million factory complex in eastern China's Suzhou Industrial Park. The 50,000-sq.-m. facility complex specializes in the R&D, production and marketing of anti-cancer drugs globally. The company's core products include liposomal technology-based specialty drugs, biologics and innovative drugs.
 
The first stage of the new factory complex includes an oral anti-cancer drug plant with separate production facilities for cytotoxics and non-cytotoxics, an injected anti-cancer drug plant, and a GMP pilot plant with 500L cell culture/ purification/filling capacity. The company will begin the second-stage of construction to expand its production scale.

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO